  Abbreviations, acronyms & symbols   
  ----------------------------------- --------------------------------------------------
  ADQI                                Acute Dialysis Quality Initiative
  AKI                                 Acute Kidney Injury
  AKIN                                Acute Kidney Injury Network
  CABG                                Coronary Artery Bypass Grafting
  CPB                                 Cardiopulmonary Bypass
  CVS                                 Cardiac Valve Surgery
  eGFR                                Estimated Glomerular Filtration Rate
  HR                                  Hazard Ratio
  KDIGO                               Kidney Disease Improving Global Outcomes
  OR                                  Odds Ratio
  RIFLE                               Risk, Injury, Failure, Loss and End-stage Kidney
                                      Disease
  SCr                                 Serum creatinine

INTRODUCTION
============

As the population ages, more patients with renal dysfunction are being referred for cardiac surgery^\[[@r01]\]^. Elevated serum creatinine (SCr) preoperatively is considered an independent risk factor for morbidity and mortality after cardiac surgery^\[[@r02],[@r03]\]^, with the overall risk of death for patients with creatinine ≥ 1.5 mg/dL ranging from 5% to 30%. Postoperatively, small changes in SCr, however small they may be, are also associated with a significant reduction in survival^\[[@r04],[@r05]\]^. Elevated SCr may be associated with increased morbidity and mortality even when its change does not meet the criteria for acute kidney injury (AKI)^\[[@r06]\]^.

Several consensus definitions have been developed to provide uniform criteria for AKI diagnosis. In 2004, the \"Acute Dialysis Quality Initiative (ADQI)\" group proposed consensus guidelines and evidence-based treatment and prevention of AKI, which were later called the RIFLE criteria (Risk, Injury, Failure, Loss and End-stage Kidney Disease)^\[[@r07]\]^. The modification of these criteria was subsequently proposed by the \"Acute Kidney Injury Network\" (AKIN, which included the ADQI group)^\[[@r08]-[@r10]\]^. More recently, the AKI study group \"Kidney Disease: Improving Global Outcomes (KDIGO)\" proposed a modified definition, combining the differences between the RIFLE and AKIN definitions^\[[@r11]\]^ ([Table 1](#t01){ref-type="table"}).

###### 

Classification and staging for RIFLE, AKIN, and KDIGO criteria.

  Class                      RIFLE SCr or GFR                                                                              Stage   AKINSCr                                                                                                                                                                  Stage   KDIGO SCr
  -------------------------- --------------------------------------------------------------------------------------------- ------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------
  Risk                       Increased Scr x 1.5 or GFR decrease \> 25% (within 7 days)                                    1       Increase in SCr ≥ 0.3 mg/dL or ≥ 150% to 200% (1.5- to 2-fold) from baseline (within 48 hours)                                                                           1       Increase in SCr by ≥ 0.3 mg/dL within 48 hours or increase in SCr 1.5 to 1.9 times baseline which is known or presumed to have occurred within the prior 7 days
  Injury                     Increased Scr x 2.0 or GFR decrease \> 50%                                                    2       Increase in SCr to more than 200% to 300% (\> 2- to 3-fold) from baseline                                                                                                2       Increase in SCr to 2.0 to 2.9 times baseline
  Failure                    Increased Scr x 3.0 or GFR decrease \> 75% or SCr ≥ 4.0 mg/dL or acute increase ≥ 0.5 mg/dL   3       Increase in SCr to more than 300% (\> 3-fold) from baseline or SCr ≥ 4.0 mg/dL with an acute increase of at least 0.5 mg/dL or initiation of renal replacement therapy   3       Increase in SCr to 3.0 times baseline or increase in SCr to ≥ 4.0 mg/dL or initiation of renal replacement therapy
  Loss                       Persistent acute renal failure = complete loss of kidney function \> 4 weeks                                                                                                                                                                                                            
  End Stage Kidney Disease   End stage of kidney disease (\> 3 months)                                                                                                                                                                                                                                               

Modified from Bellomo et al.^\[[@r07]\]^, Mehta et al.^\[[@r08]\]^ and Kidney Disease: Improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group^\[[@r11]\]^

The aim of this study was to apply the criteria for AKI based on the KDIGO classification in a population of patients with preoperative SCr above normal limits after cardiac surgery \[coronary artery bypass grafting (CABG) or cardiac valve surgery (CVS)\] and to evaluate acute worsening of renal function as a predictor of risk of 30-day mortality.

METHODS
=======

Patient selection
-----------------

This was a single-center study. We carried out a retrospective evaluation in patients from the Cardiac Surgery Intensive Care Unit at a Brazilian Medical School Center. Demographics, type of surgery, laboratory data and information of pre, peri and postoperative periods were obtained from a prospectively collected database of 2,878 patients who were older than 18 years and had undergone isolated CABG (1,786) or CVS (1,092) from January 2003 to June 2013. We excluded 51 patients with incomplete data, 23 dialysis patients and 1,886 patients with preoperative SCr within normal limits (Men - SCr ≤ 1.30 mg/dL / Women - SCr ≤ 1.00 mg/dL). After applying the exclusion criteria, 918 patients were analyzed \[549 (60%) underwent CABG and 369 (40%) underwent CVS\] ([Figure 1](#f01){ref-type="fig"}).

![Study flow chart showing patients underwent cardiac surgery and staging for acute kidney injury (AKI) based on the KDIGO criteria. CABG - coronary artery bypass grafting; CVS - cardiac valve surgery; PO - postoperative day](rbccv-29-03-0299-g01){#f01}

This study was approved by the local Research Ethics (CAAE: 5974/2008). Because of its observational nature, informed consent was waived. This research fully adheres to Resolution 466/2012 of the National Health Council (CNS).

Serum Creatinine Measurement
----------------------------

The Jaffe colorimetric method (ADVIATM 1650, Bayer, Germany) was used to measure SCr concentration. The reference value for adults is 0.6 to 1.3 mg/dL for men and 0.6 to 1.0 mg/dL for women.

Stages of AKI based on KDIGO Classification([@r11])
---------------------------------------------------

**Stage 1:** Increase in SCr ≥ 0.3 mg/dL (in 48 hours) or 1.5 to 1.9 multiplied by baseline (in 7 days);

**Stage 2:** 2.0 to 2.9 multiplied by baseline SCr;

**Stage 3:** 3.0 or more multiplied by baseline; increase in SCr ≥ 4.0 mg/dL; or beginning of renal replacement therapy regardless of a previous KDIGO stage.

Data Analysis
-------------

The criteria for AKI were applied in 918 patients in the first seven postoperative days. Due to lack of data on urinary output, only SCr was used to determine the categories of AKI. According to the changes in SCr, the patients were classified as no AKI (KDIGO 0) and AKI stages 1, 2 or 3, based on the KDIGO criteria. Glomerular filtration rate (eGFR) was estimated by the Cockcroft-Gault^\[[@r12]\]^ equation. The risk of postoperative death was assessed by EuroSCORE^\[[@r13],[@r14]\]^, in the absence of a specific tool for our population.

Statistical Analysis
--------------------

Variables are presented as absolute numbers and percentages or median and interquartile ranges (25^th^ and 75^th^ percentile) when applicable. Continuous variables were compared using the nonparametric Mann-Whitney or Kruskal-Wallis tests, and the chi-square or Fisher\'s exact test was used to compare categorical variables.

Univariate and multivariate Cox proportional hazards models (stepwise) were used to determine the association between AKI and 30-day mortality. The model was adjusted for age (years), gender (reference - female gender), type of surgery (reference - CVS), body mass index (kg/m^2^), diabetes mellitus (reference - non-diabetic), left ventricular function (reference - preserved left ventricular ejection fraction), cardiopulmonary bypass (CPB) times (min) and AKI (reference - KDIGO 0). The adjusted Hazard Ratio (HR) and 95% confidence intervals (95% CI) were calculated for the predictors. Cumulative survival graphics were built to demonstrate the AKI impact as a predictor of 30-day mortality. *P* values\<0.05 were considered statistically significant (two-tailed). The data were analyzed using the IBM SPSS Statistical Package v.20 (IBM Corporation, Armonk, NY).

RESULTS
=======

Baseline characteristics of the patients are shown in [Table 2](#t03){ref-type="table"}. Median age was 61 years and 52% of the patients were male. Twenty-seven percent of the patients had preoperative eGFR above 60 mL/min. SCr measured in the immediate postoperative period was slightly lower than the preoperative SCr suggesting hemodilution during surgery ([Table 3](#t04){ref-type="table"}).

###### 

Baseline characteristics of patients who underwent cardiac surgery.

                                                            All Patients (n = 918)                                                                         
  --------------------------------------------------------- --------------------------------- ------------------------------------------------------------ ----------
  Type of surgery                                                                                                                                          
                                                            Coronary artery bypass grafting   549 (60)                                                     
                                                            Cardiac valve surgery             369 (40)                                                     
                                                                                              Multiple cardiac valve surgery                               156 (42)
                                                                                              Cardiac valve surgery during active infective endocarditis   38 (10)
  Age (years)                                               61 (52 - 68)                                                                                   
  Male gender                                               477 (52)                                                                                       
  Weight (kg)                                               70 (61 - 80)                                                                                   
  Height (m)                                                1.63 (1.56 - 1.70)                                                                             
  Body mass index (kg/m^2^)                                 26 (23 - 29)                                                                                   
  Diabetes Mellitus                                         248 (27)                                                                                       
  Left Ventricular Systolic Dysfunction (moderate/severe)   203 (22)                                                                                       
  Intra-aortic balloon pump                                 43 (7.8)                                                                                       
  Reoperation                                               134 (15)                                                                                       
  Additive EuroScore                                        4 (2 - 6)                                                                                      
                                                            Low risk (\< 3)                   248 (27)                                                     
                                                            Intermediate risk (3 to 5)        402 (44)                                                     
                                                            High risk (5)                     268 (29)                                                     
  Cardiopulmonary bypass                                    781 (85)                                                                                       
  Total cardiopulmonary bypass time (min)                   94 (79 - 114)                                                                                  
                                                            \< 90 min                         312 (40)                                                     
                                                            90 - 120 min                      308 (40)                                                     
                                                            \> 120 min                        161 (20)                                                     
  Total number of grafts                                    3 (2 - 3)                                                                                      
  Total Intensive Care length of stay                       3 (2 - 6)                                                                                      

Q1= percentile 25; Q3= percentile 75; N= number of individuals

###### 

Renal function of patients who underwent cardiac surgery.

                                            All Patients (n = 918)                                     
  ----------------------------------------- ---------------------------------------------------------- --------------------
  Preoperative SCr (mg/dL)                  1.40 (1.20 - 1.60)                                         
  Preoperative eGFR (mL/min)                49 (39 - 60)                                               
                                            eGFR ≥ 90 mL/min                                           17 (20)
                                            eGFR 60 - 89 mL/min                                        231 (25)
                                            eGFR 30 - 59 mL/min                                        603 (66)
                                            eGFR ≤ 29 mL/min                                           67 (70)
  Serum creatinine (mg/dL)                                                                             
                                            Immediate postoperative day                                1.30 (1.10 - 1.60)
                                            1^st^ Postoperative day                                    1.50 (1.20 - 1.90)
                                            2^nd^ Postoperative day[\*](#TFN01){ref-type="table-fn"}   1.30 (1.0 - 1.80)
  AKI in the first 7 days postoperatively   391 (43)                                                   
                                            KDIGO Stage 0                                              527 (57)
                                            KDIGO Stage 1                                              318 (35)
                                            KDIGO Stage 2                                              27 (2.9)
                                            KDIGO Stage 3                                              46 (5.0)
  RRT in the first 7 days postoperatively   35 (3.8)                                                   

Q1 - percentile 25; Q3 - percentile 75; SCr - serum creatinine; eGFR - estimated glomerular filtration rate; RRT - renal replacement therapy.

There was no determination of SCr on 2^nd^ postoperative day for 34 patients

Of the 918 patients studied, 391 (43%) developed AKI: 318 (35%) stage 1, 27 (2.9%) stage 2 and 46 (5.0%) stage 3 ([Table 3](#t04){ref-type="table"}). Fewer patients in stage 2 may be because the indication for dialysis automatically classifies the patient in stage 3. Any degree of AKI was associated with a significant increase in overall mortality at 30 days compared with patients with no AKI ([Table 4](#t05){ref-type="table"}). In univariate analysis, the hazard ratio for death at 30 days was 5.4 for patients with KDIGO stage 1, 16.8 for patients with KDIGO stage 2 and 27.2 for patients with KDIGO stage 3 (*P*\<0.001 for all).

###### 

Postoperative complications of patients who underwent cardiac surgery.

                                                         All Patients (n = 918)   
  ------------------------------------------------------ ------------------------ ----------
  Readmission to the intensive care unit from the ward   73 (8.0)                 
  Prolonged intensive care length of stay (\> 14 days)   97 (11)                  
  Bleeding requiring surgical reintervention             27 (2.9)                 
  New atrial fibrillation                                86 (9.4)                 
  Postoperative reintubation (within the first 7 days)   79 (8.6)                 
  Mechanical ventilation \> 24 hours                     135 (17)                 
  Mediastinitis                                          30 (3.3)                 
  Type I neurological injury                             42 (4.6)                 
  30-day mortality                                       96 (10)                  
                                                         KDIGO Stage 0            15 (2.8)
                                                         KDIGO Stage 1            46 (14)
                                                         KDIGO Stage 2            10 (37)
                                                         KDIGO Stage 3            25 (54)

Q1 - percentile 25; Q3 - percentile 75; N - number of individuals

Patients with AKI had higher EuroSCORE scores, but there was no difference in the percentage of patients at low, intermediate and high risk among the groups ([Table 5](#t06){ref-type="table"}). The 30-day mortality rate increased progressively in all KDIGO stages ([Table 4](#t05){ref-type="table"}). Time on CPB and intensive care length of stay also increased ([Table 5](#t06){ref-type="table"}). The proportion of patients who required mechanical ventilation for more than 24 hours after surgery increased from 6.3% for patients with KDIGO 0 to 67% among those with KDIGO 3 ([Table 5](#t06){ref-type="table"}). Of the patients with KDIGO 3, 76% required dialysis with a 30-day mortality rate of 66%. However, patients treated with dialysis were more severely ill, as demonstrated by the EuroSCORE calculated preoperatively \[4 (2-6) vs. 8 (5-10)\], *P*\<0.001.

###### 

Demographic data of patients who underwent cardiac surgery based on the KDIGO criteria.

                                       KDIGO 0 N = 527              KDIGO 1 N = 318      KDIGO 2N = 27        KDIGO 3N = 46                  
  ------------------------------------ ---------------------------- -------------------- -------------------- -------------------- --------- -------
  Coronary artery bypass grafting      319 (61)                     190 (60)             16 (59)              24 (52)              0.745     
  Cardiac valve surgery                208 (39)                     128 (40)             11 (41)              22 (48)                        
                                       Multiple CVS                 81 (15)              60 (19)              5 (19)               10 (22)   0.533
                                       CVS during active IE         21 (4.0)             9 (2.8)              1 (3.7)              7 (15)    0.006
  Age (years)                          60 (51 - 67)                 63 (55 - 59)         64 (58 - 70)         66 (56 - 73)         \<0.001   
  Male gender                          250 (47)                     185 (58)             13 (48)              29 (63)              0.009     
  Weight (kg)                          70 (61 - 79)                 71 (62 - 80)         70 (65 - 82)         69 (57 - 83)         0.444     
  Height (m)                           1.62 (1.55 - 1.69)           1.64 (1.57 - 1.70)   1.62 (1.52 - 1.68)   1.66 (1.60 - 1.72)   0.049     
  Body mass index (kg/m^2^)            26 (24 - 30)                 27 (24 - 29)         28 (24 - 32)         25 (22 - 29)         0.150     
  Diabetes Mellitus                    127 (24)                     103 (32)             9 (33)               9 (20)               0.032     
  LVSD (moderate/severe)               118 (22)                     71 (22)              6 (22)               8 (17)               0.890     
  Intra-aortic balloon pump            18 (3.4)                     19 (6.0)             3 (11)               3 (6.5)              0.081     
  Preoperative SCr (mg/dL)             1.40 (1.20 - 1.60)           1.50 (1.30 - 1.80)   1.40 (1.20 - 1.40)   1.65 (1.40 - 2.10)   \<0.001   
  Preoperative eGFR (mL/min)           51 (42 - 63)                 47 (38 - 58)         53 (45 - 65)         39 (28 - 52)         \<0.001   
  Reoperation                          63 (12)                      52 (16)              5 (19)               14 (30)              0.004     
  Additive EuroSCORE                   4 (2 - 5)                    4 (2 - 6)            5 (2 - 7)            7 (4 - 9)            \<0.001   
                                       Low risk (\< 3)              187 (35)             115 (36)             8 (30)               22 (48)    
                                       Intermediate risk (3 to 5)   218 (41)             126 (40)             8 (30)               18 (39)   0.190
                                       High risk (5)                122 (23)             77 (24)              11 (41)              6 (13)     
  CPB                                  422 (80)                     293 (92)             25 (93)              41 (89)              \<0.001   
  Total CPB time (min)                 90 (76 - 109)                100 (84 - 116)       100 (76 - 122)       110 (90 - 145)       \<0.001   
                                       \< 90 min                    190(36)              106 (33)             12 (44)              16 (35)    
                                       90 - 120 min                 170 (32)             109 (34)             9 (33)               18 (39)   0.658
                                       \> 120 min                   74 (14)              61 (19)              4 (15)               8 (17)     
  Total ICU length of stay             2 (2 - 4)                    3 (2 - 8)            4 (2 - 12)           8 (3 - 19)           \<0.001   
  Mechanical ventilation \> 24 hours   33 (6.3)                     60 (19)              11 (41)              31 (67)              \<0.001   

CVS - cardiac valve surgery; IE - infective endocarditis; LVSD - left ventricular systolic dysfunction; SCr - serum creatinine; eGFR - estimated glomerular filtration rate; CPB - cardiopulmonary bypass; ICU - intensive care unit

Cox regression analysis
-----------------------

In a multivariate analysis, age (years), CPB time (minutes) and AKI (KDIGO 1-3) were independent predictors of 30-day mortality, with KDIGO stage 3 being the strongest predictor. Male gender had a reduced risk of death at 30 days ([Table 6](#t07){ref-type="table"}, [Figure 2](#f02){ref-type="fig"}). Subgroup analysis (CABG and CVS) demonstrated similar results, except for reduced risk of death among male patients who underwent CABG (data not shown).

###### 

Cox proportional hazard model considering all patients who underwent cardiac surgery for predictors of 30-day mortality.

                                            HR (CI 95%)             *P*-value
  ----------------------------------------- ----------------------- -----------
  Age (years)                               1.03 (1.01 - 1.05)      0.007
  Male gender                               0.63 (0.42 - 0.95)      0.028
  Total cardiopulmonary bypass time (min)   1.01 (1.01 - 1.02)      \< 0.001
  KDIGO Stage 0                             Reference                
  KDIGO Stage 1                             4.76 (2.55 - 8.88)      \< 0.001
  KDIGO Stage 2                             13.54 (5.77 - 31.78)    \< 0.001
  KDIGO Stage 3                             20.81 (10.14 - 42.69)   \< 0.001

HR - Hazard Ratio; CI - confidence interval

![Overall survival curves of patients who underwent cardiac surgery, according to the KDIGO criteria.](rbccv-29-03-0299-g02){#f02}

DISCUSSION
==========

In our study, AKI after CABG or CVS was found to be common and associated with high rates of prolonged intensive care length of stay, morbidity and mortality. This study also demonstrated the importance of KDIGO AKI criteria as a powerful predictor of 30-day mortality in patients with preoperative SCr above normal limits. We found a higher risk of death in those with poor renal function as well as those who required dialysis; however, even slight increases in SCr postoperatively (KDIGO stage 1) were associated with a significant increase in mortality.

The reasons why small changes in SCr correlated with increased hospital mortality are not entirely clear. Possible explanations include the adverse effects of decreased renal function, such as volume overload, anemia, uremia, acidosis, electrolyte disturbances, and increased risk of infections^\[[@r11],[@r15]\]^. Visual analysis of the survival curves graph of our study showed a continuous decrease of survival in patients who developed AKI, with a higher risk of death within the first week postoperatively ([Figure 2](#f02){ref-type="fig"}).

Preoperative renal dysfunction is known as a postoperative risk predictor; however, in tools such as EuroSCORE^\[[@r13],[@r14]\]^, InsCor^\[[@r16]\]^, and Parsonnet^\[[@r17]\]^, preoperative renal dysfunction is considered a risk factor only in cases of advanced kidney disease (SCr\>2.00 or 2.26 mg/dL) or in patients on dialysis. In its update published in 2012, called EuroSCORE II^\[[@r03]\]^, assessment of renal function was included by calculating the eGFR, with values below 85 mL/min being a risk factor.

Estimates of preoperative renal function based on eGFR show that over 75% of patients undergoing CABG have an eGFR below 90 mL/min^\[[@r18]\]^, highlighting the importance and high prevalence of renal dysfunction in patients undergoing heart surgery. Furthermore, these patients are older and have more comorbidities, such as cerebrovascular disease, peripheral artery disease, chronic obstructive pulmonary disease and diabetes mellitus^\[[@r18]\]^.

Several studies have shown that slight changes in renal function have a significant impact on short and long term outcomes in patients undergoing cardiac surgery^\[[@r05],[@r19]-[@r23]\]^. Other studies suggest that intraoperative factors such as CPB times are important contributors to postoperative renal dysfunction^\[[@r24]-[@r26]\]^, as observed in our study (OR 1.01 - 95% CI 1.01 to 1.02, *P* value\<0.001 - data not shown), but others have not demonstrated this direct relationship^\[[@r27],[@r28]\]^. The use of off-pump CABG was also tested in preoperative renal dysfunction with contradictory results^\[[@r18],[@r29],[@r30]\]^.

Many publications have reported preoperative renal dysfunction as a risk predictor for morbidity and postoperative mortality. Kumar et al.^\[[@r31]\]^ identified class III obesity (BMI \> 40 kg/m^2^) as an independent predictor of AKI after on-pump CABG, and Brown et al.^\[[@r32]\]^ found high rates of readmission within 30 days after cardiac surgery in patients who developed AKI. Zakeri et al.^\[[@r22]\]^ evaluated patients with mild to moderate impaired renal function (SCr \< 2.26 mg/dL) who underwent CABG. Operative mortality was higher in this group of patients as well as the need for dialysis and occurrence of stroke postoperatively. Both the measurement of SCr as well as eGFR (\< 60 mL/min) were independent predictors of hospital mortality and in a 3-year follow-up. Cooper et al.^\[[@r33]\]^ evaluated more than 483,000 patients using the American Society of Thoracic Surgeons database. Seventy-eight percent of patients had some degree of preoperative (CrCl \< 90 mL/min) renal dysfunction. Mortality was inversely proportional to the renal function. In an adjusted model, the eGFR was one of the strongest predictors of morbidity and hospital mortality.

Study limitations
-----------------

Our study has several limitations. First, these data originated from a single center. Although data were collected prospectively, the analysis was performed retrospectively. There was no determination of cause of death, which did not allow us to differentiate between cardiovascular death and death from all causes. Several known and unknown confounding variables could theoretically have influenced the observed mortality rates. Despite the use of multivariate models for control and adjustment of some of these variables, the possibility of the presence of other unknown confounders cannot be ruled out.

CONCLUSION
==========

The development of AKI, based on KDIGO criteria, correlated with increased morbidity and was a robust predictor of 30-day mortality in patients with preoperative baseline SCr above normal limits undergoing coronary artery bypass grafting or cardiac valve surgery.

  Authors\' roles & responsibilities   
  ------------------------------------ ---------------------------------------------------------------------------------------------------------
  MNM                                  Design of the project; data collection; statistical analysis; discussion of results; manuscript writing
  MAN                                  Discussion of results; manuscript writing, article review
  LNM                                  Discussion of results; manuscript writing, article review
